Literature DB >> 3397703

Estrous influence on surgical cure of a mouse breast cancer.

H V Ratajczak1, R B Sothern, W J Hrushesky.   

Abstract

We have studied the effect of estrous stage, as reflected by vaginal cellularity, at the time of surgical resection of an estrogen receptor-bearing mammary adenocarcinoma upon the metastatic potential of that tumor in the C3HeB/FeJ mouse. Presence of the tumor prolonged the length of the estrous cycle by approximately 25% and removal of the tumor returned the cycle to its usual duration. Neither estrous stage at tumor implant nor size of tumor at resection (within a small range) had significant independent effects upon differences observed in the incidence of subsequent pulmonary metastases. However, estrous stage at time of surgical removal of the tumor, as reflected by cell types in vaginal smear, markedly affected whether or not metastases ultimately appeared. Because the estrous cycle in mice, comparable to the human menstrual cycle, reflects high-amplitude, rhythmic changes in hormone concentrations, it may be that the hormonal status of a women at the time of tumor resection is an important determinant of whether or not that breast cancer ultimately metastasizes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3397703      PMCID: PMC2188982          DOI: 10.1084/jem.168.1.73

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  THE INFLUENCE OF THE ESTRUS CYCLE, PREGNANCY AND OVARIECTOMY ON RES ACTIVITY.

Authors:  T NICOL; B VERON-ROBERTS
Journal:  J Reticuloendothel Soc       Date:  1965-05

2.  Quantitative differences in immune responses during the various stages of the estrous cycle in female BALB/c mice.

Authors:  U Krzych; H R Strausser; J P Bressler; A L Goldstein
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

3.  Metastasis results from preexisting variant cells within a malignant tumor.

Authors:  I J Fidler; M L Kripke
Journal:  Science       Date:  1977-08-26       Impact factor: 47.728

4.  Impaired immunologic reactivity and recurrence following cancer surgery.

Authors:  F R Eilber; D L Morton
Journal:  Cancer       Date:  1970-02       Impact factor: 6.860

5.  Seasonality in the occurrence of breast cancer.

Authors:  P Cohen; Y Wax; B Modan
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

6.  Fluoresceinated estrone binding by human and mouse breast cancer cells.

Authors:  B Fisher; N Gunduz; S Zheng; E A Saffer
Journal:  Cancer Res       Date:  1982-02       Impact factor: 12.701

7.  Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells.

Authors:  G Poste; J Doll; I J Fidler
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

8.  Sequential evaluation of general immune competence in cancer patients: correlation with clinical course.

Authors:  F R Eilber; J A Nizze; D L Morton
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

9.  Ovarian-independent fluctuations of estradiol receptor levels in mammalian tissues.

Authors:  A Hughes; H I Jacobson; R K Wagner; P W Jungblut
Journal:  Mol Cell Endocrinol       Date:  1976-10       Impact factor: 4.102

10.  Natural killer cells, bone, and the bone marrow: studies in estrogen-treated mice and in congenitally osteopetrotic (mi/mi) mice.

Authors:  W E Seaman; T D Gindhart; J S Greenspan; M A Blackman; N Talal
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

View more
  12 in total

1.  Timing of surgery during the menstrual cycle and prognosis of breast cancer.

Authors:  R A Badwe; I Mittra; R Havaldar
Journal:  J Biosci       Date:  2000-03       Impact factor: 1.826

2.  Menstrual history and breast cancer surgery.

Authors:  S A Gruber; K L Nichol; R B Sothern; M E Malone; J D Potter; D Lakatua; W J Hrushesky
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

3.  Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients.

Authors:  W Jäger; W Sauerbrei
Journal:  Breast Cancer Res Treat       Date:  1995-06       Impact factor: 4.872

4.  Serum levels of sex hormones and corticosterone throughout 4- and 5-day estrous cycles in Fischer 344 rats and their simulation in ovariectomized females.

Authors:  S Haim; G Shakhar; E Rossene; A N Taylor; S Ben-Eliyahu
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

5.  Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study.

Authors:  Clive S Grant; James N Ingle; Vera J Suman; Daniel A Dumesic; D Lawrence Wickerham; Richard D Gelber; Patrick J Flynn; Lorna M Weir; Mattia Intra; Wayne O Jones; Edith A Perez; Lynn C Hartmann
Journal:  J Clin Oncol       Date:  2009-06-01       Impact factor: 44.544

6.  Creation of a stable mammary tumor cell line that maintains fertility-cycle tumor biology of the parent tumor.

Authors:  Shaojin You; Wei Li; Minoru Kobayashi; Yin Xiong; William Hrushesky; Patricia Wood
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Jul-Aug       Impact factor: 2.416

Review 7.  Timing of breast surgery in premenopausal breast cancer patients.

Authors:  Miny Samuel; Khin Lay Wai; Victoria K Brennan; Wei Sean Yong
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

8.  Timing within the oestrous cycle modulates adrenergic suppression of NK activity and resistance to metastasis: possible clinical implications.

Authors:  S Ben-Eliyahu; G Shakhar; K Shakhar; R Melamed
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

9.  Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient--fact or fallacy.

Authors:  K Holli; J Isola; M Hakama
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

10.  Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: the ITS Study.

Authors:  H Thorpe; S R Brown; J R Sainsbury; T J Perren; V Hiley; M Dowsett; A Nejim; J M Brown
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.